Avicanna (TSE:AVCN) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Avicanna Inc., a biopharmaceutical company, has successfully completed a non-brokered private placement, raising $1.986 million through the sale of over 6.6 million units. These funds are earmarked for general working capital, administrative expenses, production, research, and debt repayment. The offering included common shares and warrants, with a hold period of four months in Canada.
For further insights into TSE:AVCN stock, check out TipRanks’ Stock Analysis page.